BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27476140)

  • 1. Colorectal anticancer activities of polymethoxylated 3-naphthyl-5-phenylpyrazoline-carbothioamides.
    Shin SY; Ahn S; Yoon H; Jung H; Jung Y; Koh D; Lee YH; Lim Y
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4301-9. PubMed ID: 27476140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological evaluation of 2-pyrazolinyl-1-carbothioamide derivatives against HCT116 human colorectal cancer cell lines and elucidation on QSAR and molecular binding modes.
    Kim BS; Shin SY; Ahn S; Koh D; Lee YH; Lim Y
    Bioorg Med Chem; 2017 Oct; 25(20):5423-5432. PubMed ID: 28811071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzochalcones bearing pyrazoline moieties show anti-colorectal cancer activities and selective inhibitory effects on aurora kinases.
    Shin SY; Yoon H; Hwang D; Ahn S; Kim DW; Koh D; Lee YH; Lim Y
    Bioorg Med Chem; 2013 Nov; 21(22):7018-24. PubMed ID: 24095020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer and structure-activity relationship evaluation of 3-(naphthalen-2-yl)-N,5-diphenyl-pyrazoline-1-carbothioamide analogs of chalcone.
    Lee Y; Kim BS; Ahn S; Koh D; Lee YH; Shin SY; Lim Y
    Bioorg Chem; 2016 Oct; 68():166-76. PubMed ID: 27543822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of polyphenols with 4,6-diphenylpyrimidin-2-amine derivatives for inhibition of Aurora kinase A.
    Lee YH; Park J; Ahn S; Lee Y; Lee J; Shin SY; Koh D; Lim Y
    Daru; 2019 Jun; 27(1):265-281. PubMed ID: 31154600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of human monoamine oxidase inhibitory activities of some 3,5-diaryl-N-substituted-4,5-dihydro-1H-pyrazole-1-carbothioamide derivatives.
    Sentürk K; Tan OU; Ciftçi SY; Uçar G; Palaska E
    Arch Pharm (Weinheim); 2012 Sep; 345(9):695-702. PubMed ID: 22674756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents.
    Lv PC; Li HQ; Sun J; Zhou Y; Zhu HL
    Bioorg Med Chem; 2010 Jul; 18(13):4606-14. PubMed ID: 20627597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase.
    Maccioni E; Alcaro S; Orallo F; Cardia MC; Distinto S; Costa G; Yanez M; Sanna ML; Vigo S; Meleddu R; Secci D
    Eur J Med Chem; 2010 Oct; 45(10):4490-8. PubMed ID: 20702005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological evaluation, and molecular docking studies of N,1,3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agents.
    Li X; Lu X; Xing M; Yang XH; Zhao TT; Gong HB; Zhu HL
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3589-93. PubMed ID: 22572580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromenylchalcones showing cytotoxicity on human colon cancer cell lines and in silico docking with aurora kinases.
    Shin SY; Yoon H; Ahn S; Kim DW; Kim SH; Koh D; Lee YH; Lim Y
    Bioorg Med Chem; 2013 Jul; 21(14):4250-8. PubMed ID: 23719279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro cytotoxic activity evaluation of novel heterocycle bridged carbothioamide type isosteviol derivatives as antitumor agents.
    Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1343-6. PubMed ID: 23347685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and cytotoxicity studies of novel benzhydrylpiperazine carboxamide and thioamide derivatives.
    Gurdal EE; Durmaz I; Cetin-Atalay R; Yarim M
    J Enzyme Inhib Med Chem; 2014 Apr; 29(2):205-14. PubMed ID: 23391169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory Effect of Synthetic Flavone Derivatives on Pan-Aurora Kinases: Induction of G2/M Cell-Cycle Arrest and Apoptosis in HCT116 Human Colon Cancer Cells.
    Shin SY; Lee Y; Kim BS; Lee J; Ahn S; Koh D; Lim Y; Lee YH
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30562979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H and 13C NMR spectral assignments of chalcones bearing pyrazoline-carbothioamide groups.
    Yoon H; Ahn S; Park M; Kim DW; Kim SH; Koh D; Lim Y
    Magn Reson Chem; 2013 Aug; 51(8):500-8. PubMed ID: 23784987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents.
    Wang HH; Qiu KM; Cui HE; Yang YS; Yin-Luo ; Xing M; Qiu XY; Bai LF; Zhu HL
    Bioorg Med Chem; 2013 Jan; 21(2):448-55. PubMed ID: 23245802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues.
    Ahsan MJ; Samy JG; Soni S; Jain N; Kumar L; Sharma LK; Yadav H; Saini L; Kalyansing RG; Devenda NS; Prasad R; Jain CB
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5259-61. PubMed ID: 21807509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 4-aminoquinazoline--urea derivatives as Aurora kinase inhibitors with antiproliferative activity.
    Cai J; Li L; Hong KH; Wu X; Chen J; Wang P; Cao M; Zong X; Ji M
    Bioorg Med Chem; 2014 Nov; 22(21):5813-23. PubMed ID: 25270403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1H and 13C NMR spectral assignments of 18 novel polymethoxylated naphthochalcones bearing pyrazoline-1-carbothioamide groups.
    Jung H; Ahn S; Park M; Yoon H; Noh HJ; Kim SY; Yoo JS; Koh D; Lim Y
    Magn Reson Chem; 2015 May; 53(5):383-90. PubMed ID: 25907413
    [No Abstract]   [Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.
    Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL
    Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.